2009-11-16 05:15:21 - Bayer AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile - a new market research report on companiesandmarkets.com

www.companiesandmarkets.com/Summary-Company-Profile/bayer-ag-pha ..

Bayer AG is the management holding company for the Bayer Group. The Company’s business operations are organized into three subgroups: HealthCare, CropScience and MaterialScience, supported by the service companies Bayer Business Services, Bayer Technology Services and Currenta. Bayer HealthCare is involved in the research, development and manufacture of health products for people and animals. Bayer CropScience is engaged in the crop protection and non-agricultural pest control. Bayer MaterialScience supplies materials, such as polycarbonates and polyurethanes, and system solutions such as coatings, for a range of everyday uses. In October 2008, Bayer AG launched its new anticoagulant pill Xarelto in Britain and Germany, which has been granted approval in the European Union. The Company has subsidiaries operating in Europe, Asia-Pacific, North

 

 

America, Latin America, Africa and Middle East. Bayer Schering Pharma AG became a wholly owned subsidiary of Bayer AG on September 25, 2008.

Bayer AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Summary

Bayer AG (Bayer) is the management holding company for the Bayer Group. The company carries out its operations through three business segments, namely, Bayer HealthCare, Bayer CropScience and Bayer MaterialScience. The major products offered by the company include, ethical pharmaceuticals and other healthcare products, polymers and agricultural products. During 2008, Bayer launched its new anticoagulant pill Xarelto in Germany and Britain, and in the same year ‘Bayer Schering Pharma AG’ became a wholly owned subsidiary of the company. The company acquired DIREVO Biotech AG during 2008.

The Bayer AG - Pharmaceuticals & Healthcare - Deals and Alliances Profile is an essential source for company data and information. The profile examines the company’s key business structure and operations, history and products, and provides summary analysis of its key revenue lines and strategy as well as highlighting the company’s major recent financial deals.

Scope

- Provides key company information for business intelligence needs
- Gives information on the company’s major recent financial deals including Mergers and Acquisitions, asset transactions, PE/VC deals, equity offerings, debt offerings and partnerships.
- Data is supplemented with details on the company’s history, key executives, business description, locations and subsidiaries as well as a list of products and services and the latest available company statement.

Reasons to buy

- A quick ""one-stop-shop"" to understand the company.
- Support sales activities by understanding your customers’ businesses.
- Qualify prospective partners and suppliers.
- Understand and respond to your competitors’ business structure, strategy and prospects through.
- Understanding the key deals which have shaped the company.